March 31, 2026

ANI Pharmaceuticals, Inc. (ANIP)

⚠️ No article content returned.

..

Kiniksa Pharmaceuticals (KNSA): Growth Potential with 25.55% Upside and Strong Buy Ratings

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) has emerged as a noteworthy player in the healthcare sector, particularly in the niche of specialty and generic drug manufacturing. With a market capitalization..

Guardian Pharmacy Services, Inc (GRDN): Investor Outlook and Growth Prospects with a Potential 6.31% Upside

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN) has emerged as a noteworthy player in the healthcare sector, focusing on medical care facilities across the United States. With a market capitalization of..

Neogen Corporation (NEOG) Stock Analysis: Navigating a 30.94% Potential Upside Amidst Challenges

Neogen Corporation (NEOG), a key player in the healthcare sector, particularly within the medical devices industry, is currently drawing attention from investors due to its intriguing potential upside of 30.94%...

Apellis Pharmaceuticals (APLS) Investor Outlook: Navigating Potential Upside in a Volatile Biotech Market

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a noteworthy player in the biotechnology sector, drawing investors’ attention with its focus on developing novel therapies for diseases with significant unmet needs. Headquartered..

National HealthCare Corporation (NHC) Stock Analysis: Navigating the Healthcare Sector with a Solid Revenue Growth

National HealthCare Corporation (NYSE: NHC) stands as a significant player in the healthcare industry, primarily focusing on medical care facilities across the United States. With a market capitalization of $2.52..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Evaluating the 12.56% Potential Upside

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stands as a compelling entity in the biotechnology sector, capturing investor attention with its innovative pipeline and a notable potential upside of 12.56%, according to..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring an 87.97% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering company in the field of gene editing, is capturing the attention of investors with its robust pipeline of innovative therapies and a significant..

Disc Medicine, Inc. (IRON) Stock Analysis: Unveiling a 64.80% Upside Potential

Disc Medicine, Inc. (NASDAQ: IRON) is capturing the attention of investors with its promising upside potential and a solid pipeline in the biotechnology sector. With a market capitalization of $2.32..

Vericel Corporation (VCEL) Stock Analysis: Exploring an 81.44% Potential Upside in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL) stands at a crucial juncture in the healthcare sector, with its promising position in the biotechnology industry capturing the attention of investors. With a market capitalization..

NewAmsterdam Pharma Company N.V. (NAMS) Stock Analysis: Eyeing a 65% Potential Upside

NewAmsterdam Pharma Company N.V. (NAMS) is making waves in the biotechnology sector with a promising pipeline poised to address significant unmet needs in cardiometabolic and Alzheimer’s diseases. Based in Naarden,..

Belite Bio, Inc (BLTE): Investor Outlook with a 41.78% Potential Upside

Belite Bio, Inc (NASDAQ: BLTE) is capturing the attention of investors with its significant potential upside of 41.78%, as derived from its current stock price and analyst target estimates. As..

LifeStance Health Group, Inc. (LFST): Analyst Ratings Suggest a 57% Potential Upside for This Healthcare Stock

Investors with a keen eye on the healthcare sector may find LifeStance Health Group, Inc. (NASDAQ: LFST) a compelling addition to their portfolios. With a current market capitalization of $2.39..

Evotec SE (EVO) Stock Analysis: Unveiling a Potential 119% Upside for Investors

Evotec SE (EVO) presents an intriguing opportunity for investors willing to navigate the complexities of the healthcare sector. As a key player in the drug discovery and development industry, Evotec..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: A Compelling 62.81% Upside Potential

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) stands out in the healthcare sector with a market capitalization of $3.6 billion. Specializing in buprenorphine-based prescription drugs, the company plays a critical role in..

Enovis Corporation (ENOV) Stock Analysis: A Promising Upside with a 108% Growth Potential

Enovis Corporation (ENOV), a key player in the healthcare sector specializing in medical devices, is drawing considerable attention from investors due to its significant growth potential. With a market capitalization..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Navigating Challenges with Strategic Insights

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a key player in the healthcare sector, operates within the medical care facilities industry. With a market capitalization of $2.11 billion, Acadia provides a..

Supernus Pharmaceuticals (SUPN): Investor Outlook Reveals 28% Potential Upside Amid Strong Revenue Growth

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a noteworthy entity in the healthcare sector, has captured investor attention with its promising 28% potential upside. This biopharmaceutical company, specializing in treatments for central..

Mesoblast Limited (MESO) Stock Analysis: Exploring a 143% Potential Upside in Regenerative Medicine

Mesoblast Limited (NASDAQ: MESO), an Australian biotechnology company specializing in regenerative medicine, is making significant strides in the healthcare sector. With a market capitalization of $1.88 billion, Mesoblast is positioned..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 123% Potential Upside

For investors keen on the biotechnology sector, Dyne Therapeutics, Inc. (NASDAQ: DYN) presents an intriguing opportunity, particularly given its impressive potential upside of 123.45%. As a clinical-stage company specializing in..

Search

Funds

March 31, 2026

Search

Funds

March 31, 2026

FTSE 100

Funds